85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details
臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-jRCT2071210016 | 11/07/2021 | 28/04/2021 | Drug-drug interaction study of TAS-115 with lansoprazole in healthy subjects | Drug-drug interaction study of TAS-115 with lansoprazole in healthy subjects | Idiopathic pulmonary fibrosis | Day 1:TAS-115 will be orally administered. Day11-Day14:Lansoprazole will be orally administered once a day. Day 15:Lansoprazole will be orally administered and TAS-115 will be orally administered 1 hour later. | Huang Jinhong | NULL | Complete | >= 20age old | < 40age old | Male | 14 | Phase 1 | Japan |
| 2 | NCT04965298 (ClinicalTrials.gov) | June 16, 2021 | 7/7/2021 | Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole | The Effectiveness and Risks of Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole: a Randomised Placebo-controlled Multi-centre Clinical Trial | Idiopathic Pulmonary Fibrosis | Drug: Lansoprazole;Other: Matched placebo | Norfolk and Norwich University Hospitals NHS Foundation Trust | Norwich Clinical Trials Unit | Recruiting | 40 Years | N/A | All | 298 | Phase 3 | United Kingdom |
| 3 | EUCTR2020-000041-14-GB (EUCTR) | 19/06/2020 | 08/07/2020 | Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole | The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): a randomised placebo-controlled multi-centre clinical trial - TIPAL | Idiopathic Pulmonary Fibrosis MedDRA version: 21.1;Level: PT;Classification code 10021240;Term: Idiopathic pulmonary fibrosis;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | Trade Name: Lansoprazole Product Name: Lansoprazole INN or Proposed INN: lansoprazole Other descriptive name: N/A | Norfolk and Norwich University Hospitals NHS Foundation Trust | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 298 | Phase 3 | United Kingdom |